Global structural heart devices market expected to generate around USD 17,152 million by 2025, at a CAGR of around 9.9% between 2019 and 2025. Structural heart devices are used to maintain the normal structure of a human heart. Due to the various congenital defects and cardiovascular infections, heart muscles lose their shape.
Structural Heart Devices Market
The report covers a forecast and an analysis of the structural heart devices market on a global and regional level. The study provides historical data from 2016, 2017, and 2018 along with a forecast from 2019 to 2025 based revenue (USD Million). The study includes the drivers and restraints of the Structural Heart Devices Market along with the impact they have on the demand over the forecast time period. Additionally, the report includes the study of opportunities available in the Structural Heart Devices Market on a global level.
In order to give the users of this report a comprehensive view of the Structural Heart Devices Market, we have included a competitive landscape and an analysis of Porter’s Five Forces model of the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments in the market, including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.
The study provides a decisive view of the Structural Heart Devices Market by segmenting the market based on product type, indication, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025.
By product type, the structural heart devices market includes heart valve devices, occluders, and delivery systems, annuloplasty rings, and accessories. By indication, the structural heart devices market is segmented into atrial septal defect (ASD), patent foramen ovale (PFO), ventricular septal defect (VSD), and aortic valve stenosis. By end-user, the structural heart devices market is segmented into hospitals, ambulatory surgical centers, and others.
The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further segmentation into major countries, including the U.S., Germany, France, UK, China, Japan, India, and Brazil.
Some major market players of the global structural heart devices include Abbott Laboratories, Medtronic Plc., Endologix Inc., LivaNova Plc., Boston Scientific Corporation, CryoLife Inc., Cook Group Incorporated, Edwards Lifesciences Corporation, and W. L. Gore & Associates, Inc., among others.
This report segments the global structural heart devices market into:
Global Structural Heart Devices Market: Product Type Analysis
Global Structural Heart Devices Market: Indication Analysis
Global Structural Heart Devices Market: End-User Analysis
Global Structural Heart Devices Market: Regional Analysis